Präsentiert durch Paradigm Publishing Services
Princeton University Press
Kapitel
Lizenziert
Nicht lizenziert
Erfordert eine Authentifizierung
11 HIV Prevention: Implementing Proven Prevention Interventions to Control the Global Epidemic
-
, und
Sie haben derzeit keinen Zugang zu diesem Inhalt.
Sie haben derzeit keinen Zugang zu diesem Inhalt.
Kapitel in diesem Buch
- Frontmatter i
- CONTENTS v
- PREFACE vii
- CONTRIBUTORS xi
- 1 The Structure and Biology of HIV-l: Introduction 1
- 2 The Genetics of HIV-1 44
- 3 Nucleoside Inhibitors of HIV Reverse Transcriptase and the Problem of Drug Resistance 100
- 4 Non-Nucleoside Reverse Transcriptase Inhibitors of HIV-1 132
- 5 HIV-1 Protease Inhibitors 172
- 6 The Biology and Biochemistry of Integration as a Target for Chemotherapeutic Intervention 223
- 7 Chemokine Receptors in HIV Infection and AIDS 250
- 8 Novel HIV-1 Therapeutic Targets: Regulatory Functions 294
- 9 Novel HIV-1 Therapeutic Targets: Accessory Functions 328
- 10 The Interface between the Pathogenesis and Treatment of HIV Infection 384
- 11 HIV Prevention: Implementing Proven Prevention Interventions to Control the Global Epidemic 441
- 12 The Immunobiology of HIV-1 Infection 459
- 13 HIV Vaccines 2000: Prospects and Challenges 481
- INDEX 511
Kapitel in diesem Buch
- Frontmatter i
- CONTENTS v
- PREFACE vii
- CONTRIBUTORS xi
- 1 The Structure and Biology of HIV-l: Introduction 1
- 2 The Genetics of HIV-1 44
- 3 Nucleoside Inhibitors of HIV Reverse Transcriptase and the Problem of Drug Resistance 100
- 4 Non-Nucleoside Reverse Transcriptase Inhibitors of HIV-1 132
- 5 HIV-1 Protease Inhibitors 172
- 6 The Biology and Biochemistry of Integration as a Target for Chemotherapeutic Intervention 223
- 7 Chemokine Receptors in HIV Infection and AIDS 250
- 8 Novel HIV-1 Therapeutic Targets: Regulatory Functions 294
- 9 Novel HIV-1 Therapeutic Targets: Accessory Functions 328
- 10 The Interface between the Pathogenesis and Treatment of HIV Infection 384
- 11 HIV Prevention: Implementing Proven Prevention Interventions to Control the Global Epidemic 441
- 12 The Immunobiology of HIV-1 Infection 459
- 13 HIV Vaccines 2000: Prospects and Challenges 481
- INDEX 511